Ditte Riber is a biotech innovator at Zealand Pharma, specializing in peptide drug design and intellectual property. As the inventor of Survodutide and Dasiglucagon/Zegalogue, both significant advancements in diabetes and obesity treatments, they are actively engaged in leading various peptide-related projects. Riber holds a PhD in organic chemistry from Aarhus University and has continued their education in biochemistry and pharmacology. Additionally, they are a certified European Patent Attorney and have extensive experience in managing research and development within the biotech industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices